Bilateral Adrenal Tumors That Appear Separately Signal Higher Cancer Risk
A 1,035-patient Mayo Clinic study finds asynchronous bilateral adrenal masses carry double the malignancy rate of simultaneous presentations.
Summary
When both adrenal glands develop tumors at different points in time rather than simultaneously, the risk of cancer is significantly elevated, according to a large Mayo Clinic retrospective study. Analyzing over 1,000 patients with bilateral adrenal masses, researchers found that 85% had matching (concordant) diagnoses in both glands, most of which were benign. However, the 15% with mismatched (discordant) diagnoses had much higher rates of malignancy. Crucially, when a second adrenal tumor appeared within two years of the first, cancer or pheochromocytoma was more than twice as likely compared to cases where the interval exceeded five years. Larger tumor size also independently predicted a dangerous diagnosis. These findings offer clinicians clearer criteria for identifying high-risk patients who need aggressive workup.
Detailed Summary
Adrenal incidentalomas are increasingly discovered on imaging performed for unrelated reasons, and when they appear in both glands, clinicians face a complex diagnostic challenge. Understanding whether bilateral adrenal masses are likely to share the same underlying cause — or represent something more sinister — has critical implications for how aggressively patients are evaluated and monitored.
This large retrospective cohort study from Mayo Clinic enrolled 1,035 adults with bilateral adrenal masses seen between 2010 and 2025. Researchers characterized the full etiologic spectrum of these lesions and specifically examined patterns of concordance (both glands having the same diagnosis) versus discordance, as well as synchronous (discovered at the same time) versus asynchronous (staggered in time) presentation.
The majority of cases — 85% — showed concordant etiologies, and of these, 76% were bilateral benign cortical lesions such as adenomas. The 15% with discordant diagnoses were far more heterogeneous: 35% benign, 31% malignant, and 34% indeterminate. Asynchronous presentation, seen in 16% of cases, was associated with significantly higher discordance (23% vs 13%) and roughly double the prevalence of malignant lesions. Among asynchronous patients, a contralateral lesion appearing within two years (vs. five or more years later) was independently associated with over 2.6 times greater odds of malignant or pheochromocytoma etiology. Larger tumor size carried an independent 6% increased odds per millimeter.
For clinicians, these data provide actionable risk-stratification benchmarks. Patients who develop a contralateral adrenal mass within a short interval after an index lesion — especially if the new tumor is large — warrant expedited and thorough evaluation for malignancy or pheochromocytoma rather than a watchful waiting approach.
Caveats include the tertiary referral center setting, which likely overrepresents complex or high-risk cases, limiting generalizability to community practice. The retrospective design also introduces inherent selection and ascertainment biases.
Key Findings
- 85% of bilateral adrenal masses share the same benign etiology; 15% are discordant and far more dangerous.
- Asynchronous presentation doubles malignancy prevalence compared to simultaneous bilateral discovery.
- Contralateral lesion appearing within 2 years carries 2.63x higher odds of malignancy or pheochromocytoma.
- Each millimeter increase in tumor size independently raises odds of malignant diagnosis by 6%.
- Discordant bilateral masses show 31% malignant rate versus predominantly benign concordant cases.
Methodology
Retrospective cohort study of 1,035 adults with bilateral adrenal masses at Mayo Clinic from 2010 to 2025. Analyses included etiology characterization, concordance/discordance classification, synchronicity timing, and multivariable logistic regression for predictors of discordance and malignant or pheochromocytoma contralateral lesions.
Study Limitations
The tertiary referral center setting likely enriches the cohort with complex, high-risk cases, potentially overstating malignancy rates seen in general practice. As a retrospective study, selection and ascertainment biases are inherent. Summary is based on the abstract only, as full-text was not available.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.